Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00347802 · ClinicalTrials.gov registry record · Phase 4

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

A Phase 4 study, sponsored by Innovative Medical.

Completed
Registry status
Phase 4
Development phase

NCT00347802: Completed Phase 4 study, sponsored by Innovative Medical.

NCT00347802 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00347802, a Phase 4 study, has completed, sponsored by Innovative Medical.

COMPLETED
Registry status
Phase 4
Development phase

Study Summary

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

Interventions

  • DRUG Bimatoprost 0.03%, Travoprost 0.004%

Trial Details

FieldValue
Phase Phase 4
Innovative Medical

44 total trials

What the finished NCT00347802 record still lists

NCT00347802 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which Bimatoprost 0.03%, Travoprost 0.004% is the first listed.

NCT00347802 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00347802 about?

NCT00347802 is a clinical study titled "Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%". To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

What is the current status of trial NCT00347802?

This trial is currently completed. It is a Phase 4 study.

What interventions are being tested in trial NCT00347802?

The interventions under investigation include: Bimatoprost 0.03%, Travoprost 0.004% (DRUG).

Who is sponsoring clinical trial NCT00347802?

This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.

Source: ClinicalTrials.gov NCT00347802, the US trial registry maintained by the National Library of Medicine. NCT00347802 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.